Meiji Holdings (2269) Stock Price, Fundamentals & Analysis

What 2269 does

Meiji Holdings (2269) is a stock listed on the Tokyo Stock Exchange in the Consumer Defensive sector, specifically in the Packaged Foods industry. The company operates through two segments — Food and Pharmaceuticals — and manufactures products such as milk, yogurt, cheese, ice cream, chocolate, gummy candy, infant and children’s nutrition, beauty supplements, and nutritional products. It also produces drugs for infectious diseases and central nervous system disorders, as well as vaccines, blood plasma products, generic drugs, and animal health products. Headquartered in Chuo, Japan, Meiji Holdings employs 17,103 people and has been operating since 1916. It is part of the Nikkei 225 index.

Key numbers explained

• The current price is 4,320 JPY, up +0.63% today.
• The trailing P/E ratio of 33.3 shows how much investors pay per unit of recent earnings; a higher number can signal higher growth expectations.
• The forward P/E ratio of 20.6 uses expected future earnings and is often seen as a more forward-looking valuation measure.
• The dividend yield of 2.55% represents the annual dividend as a percentage of the current price, indicating the cash return relative to the share cost.
• The ex-dividend date is Sep 29, 2026 — the first trading day on which a buyer is not entitled to the upcoming dividend.
• 81% of earnings are paid out as dividends, a high payout ratio that shows most of the company’s profit is returned to shareholders.
• The beta of 0.13 suggests the stock has historically moved much less than the overall market, a typical trait of defensive consumer staples.
• The 52-week price range of 2,907 – 4,608 JPY and a one-year price change of 41.1% show the recent trading band and the year-over-year return.
• The debt-to-equity ratio of 16.9% indicates a low level of debt compared with shareholder equity, often viewed as a conservative capital structure.

What to watch

For a stock like Meiji Holdings (2269), investors typically monitor consumer demand trends, input costs for dairy and pharmaceutical raw materials, and foreign exchange movements given its international operations. Regulatory changes in Japan or key markets can affect both the food and drug segments. The upcoming earnings report on Nov 12, 2026 will provide a fresh look at profitability and outlook. Because the company is part of the Nikkei 225, broader index movements and Japanese market sentiment can also influence its price.